1. Home
  2. DHC vs MNMD Comparison

DHC vs MNMD Comparison

Compare DHC & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DHC
  • MNMD
  • Stock Information
  • Founded
  • DHC 1998
  • MNMD 2019
  • Country
  • DHC United States
  • MNMD United States
  • Employees
  • DHC N/A
  • MNMD N/A
  • Industry
  • DHC Real Estate Investment Trusts
  • MNMD Pharmaceuticals and Biotechnology
  • Sector
  • DHC Real Estate
  • MNMD Health Care
  • Exchange
  • DHC Nasdaq
  • MNMD Nasdaq
  • Market Cap
  • DHC 856.4M
  • MNMD 811.9M
  • IPO Year
  • DHC N/A
  • MNMD N/A
  • Fundamental
  • Price
  • DHC $4.32
  • MNMD $11.91
  • Analyst Decision
  • DHC Buy
  • MNMD Strong Buy
  • Analyst Count
  • DHC 2
  • MNMD 6
  • Target Price
  • DHC $4.25
  • MNMD $26.50
  • AVG Volume (30 Days)
  • DHC 900.8K
  • MNMD 1.7M
  • Earning Date
  • DHC 11-03-2025
  • MNMD 11-06-2025
  • Dividend Yield
  • DHC 0.93%
  • MNMD N/A
  • EPS Growth
  • DHC N/A
  • MNMD N/A
  • EPS
  • DHC N/A
  • MNMD N/A
  • Revenue
  • DHC $1,522,835,000.00
  • MNMD N/A
  • Revenue This Year
  • DHC $4.05
  • MNMD N/A
  • Revenue Next Year
  • DHC $3.08
  • MNMD N/A
  • P/E Ratio
  • DHC N/A
  • MNMD N/A
  • Revenue Growth
  • DHC 4.29
  • MNMD N/A
  • 52 Week Low
  • DHC $2.00
  • MNMD $4.70
  • 52 Week High
  • DHC $4.65
  • MNMD $12.76
  • Technical
  • Relative Strength Index (RSI)
  • DHC 53.04
  • MNMD 64.95
  • Support Level
  • DHC $4.27
  • MNMD $8.77
  • Resistance Level
  • DHC $4.50
  • MNMD $12.76
  • Average True Range (ATR)
  • DHC 0.16
  • MNMD 0.81
  • MACD
  • DHC -0.05
  • MNMD 0.21
  • Stochastic Oscillator
  • DHC 29.59
  • MNMD 80.44

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Share on Social Networks: